Nexentis Technologies Inc. (NXTS) compared with its closest peers (GNPX, SXTP, ERNA, ONCO, HCWB). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Genprex, Inc. (GNPX) | $3.25M | -0.1 |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | $2.95M | -0.0 |
| Ernexa Therapeutics Inc. (ERNA) | $2.90M | — |
| Onconetix, Inc. (ONCO) | $2.56M | -0.1 |
| HCW Biologics Inc. (HCWB) | $2.45M | — |
| Oragenics, Inc. (OGEN) | $2.35M | -0.2 |
| CDT Equity Inc. (CDT) | $2.32M | -0.0 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | $2.18M | -0.3 |
| Jaguar Health, Inc. (JAGX) | $2.16M | -0.0 |
| Decoy Therapeutics Inc. (DCOY) | $2.10M | — |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
NXTS overview · NXTS earnings · NXTS financials · NXTS KPIs · NXTS investor relations · NXTS ownership · NXTS filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.